IL1B and prostate carcinoma: Our group was the first to propose a prometastatic role for IL1β in prostate cancer based on preclinical studies demonstrating that IL1β expression by PC3-ML cells permits the growth of skeletal disseminated tumors in mice, because short hairpin RNA-mediated knockdown of this cytokine significantly impairs their ability to metastasize (14).